5th International Conference on Industrial Biotechnology and Bioprocessing

CRISPR 2022 brings together investigators focused on enzymes and technologies, predominantly CRISPR-based systems, but also other promising systems and approaches, to discuss advances in the field and ways to harness genome engineering for beneficial purposes.

The Plasma Product Biotechnology Conference Series has established a reputation as the key international forum for the presentation and discussion of topics relevant to the plasma manufacturing industry.

Cell and Gene therapies are life-changing new categories of medicines whose full potential is only just beginning to emerge. They are cutting-edge and rapidly progressing fields of Biological Therapies. Both therapies aim to treat, prevent or potentially cure diseases and both approaches offer the potential to diminish the fundamental cause of genetic and acquired diseases by substituting the missing protein or cells causing the disease’s symptoms. Cell and gene therapies may offer longer lasting effects than traditional medicines. They are overlapping fields of biomedical research and treatments. However, cell and gene therapies work differently.

The conference series on Bioactive Lipids in Cancer, Inflammation and Related Diseases was started in 1989 when its first conference was held in Detroit, Michigan. Subsequent meetings were held around the globe with the next conference scheduled forOct. 30 – Nov. 2, 2022 in New Orleans, Louisiana, at the Hilton New Orleans Riverside hotel.